REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer P Seibold, A Webb, ME Aguado-Barrera, D Azria, C Bourgier, M Brengues, ... Radiotherapy and Oncology 138, 59-67, 2019 | 66 | 2019 |
External validation of a predictive model for acute skin radiation toxicity in the REQUITE breast cohort T Rattay, P Seibold, ME Aguado-Barrera, M Altabas, D Azria, GC Barnett, ... Frontiers in oncology 10, 575909, 2020 | 14 | 2020 |
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer SL Kerns, AA Morlang, SM Lee, DR Peterson, B Marples, H Zhang, ... Radiotherapy and Oncology 168, 75-82, 2022 | 9 | 2022 |
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort AJ Webb, E Harper, T Rattay, ME Aguado-Barrera, D Azria, C Bourgier, ... EBioMedicine 84, 2022 | 6 | 2022 |
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of … L van der Weijst, D Azria, P Berkovic, P Boisselier, E Briers, R Bultijnck, ... Radiotherapy and Oncology 176, 127-137, 2022 | 5 | 2022 |
(Pre) treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer JC Rosas, ME Aguado‐Barrera, D Azria, E Briers, R Elliott, ... International journal of cancer 153 (9), 1579-1591, 2023 | 4 | 2023 |
Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients ME Aguado-Barrera, L Martínez-Calvo, J Fernández-Tajes, ... Cancers 13 (6), 1447, 2021 | 3 | 2021 |
Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician … M Costa Rivas, G Huidobro Vence, JL Fírvida Pérez, B Campos Balea, ... Clinical and Translational Oncology 20, 1467-1473, 2018 | 3 | 2018 |
PD-0531 SNPS IN DNA REPAIR AND DAMAGE DETECTION GENES AND ACUTE NORMAL TISSUE TOXICITY IN PROSTATE CANCER PATIENTS L Fachal, A Gomez-Caamano, P Peleteiro, A Carballo, P Calvo-Crespo, ... Radiotherapy and Oncology, S213, 2012 | 1 | 2012 |
Reply to: Comments on"(Pre) treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer" JC Rosas, ME Aguado-Barrera, D Azria, E Briers, R Elliott, ... International journal of cancer 154 (4), 759-761, 2024 | | 2024 |
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types E Naderi, ME Aguado-Barrera, LMH Schack, L Dorling, T Rattay, L Fachal, ... JNCI Cancer Spectrum 7 (6), pkad088, 2023 | | 2023 |
Large-Scale Meta-GWAS Reveals Common Genetic Factors Linked to Radiation-Induced Acute Toxicities across Cancers E Naderi, ME Aguado-Barrera, LMH Schack, L Dorling, T Rattay, L Fachal, ... JNCI cancer spectrum 7 (6), pkad088, 2023 | | 2023 |
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer HK Jandu, CD Veal, L Fachal, C Luccarini, ME Aguado-Barrera, ... Radiotherapy and Oncology 187, 109806, 2023 | | 2023 |
Radiogenomics in lung cancer: Where are we? ME Aguado-Barrera, P Sosa-Fajardo, A Gómez-Caamaño, ... Lung Cancer 176, 56-74, 2023 | | 2023 |
Radiation Therapy for Metastatic Lung Cancer: Bone Metastasis and Metastatic Spinal Cord Compression B Taboada-Valladares, P Calvo-Crespo, A Gómez-Caamaño Advances in Radiation Oncology in Lung Cancer, 779-793, 2022 | | 2022 |
Palliative radiotherapy in CRC P Calvo-Crespo, B Taboada-Valladares, A Gómez-Caamaño Foundations of Colorectal Cancer, 429-433, 2022 | | 2022 |
Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience B Taboada Valladares, P Calvo Crespo, A Gomez Caamano, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S743-S743, 2015 | | 2015 |
Calidad de vida después recidiva bioquímica en los pacientes con cáncer de próstata.¿ Cómo y cuánto viven los pacientes después de recidiva bioquímica? A Gómez Caamaño, L León Mateos, E Fernández Fernández, ... Arch. esp. urol.(Ed. impr.), 193-206, 2012 | | 2012 |
PO-320 SINGLE FRACTION (7 GY) OF HDR-BRACHYTHERAPY AS BOOST IN BREAST-CONSERVING THERAPY: 5 YEARS RESULTS IN 139 PATIENTS B Taboada Valladares, E Gonzlez Patino, N Salvador Garrido, ... Radiotherapy and Oncology 103 (2), 1, 2012 | | 2012 |